Legend Biotech (LEGN) Long-Term Deferred Tax (2019 - 2021)
Legend Biotech's (LEGN) quarterly Long-Term Deferred Tax came in at $22.8 million in Q4 2021, down 25.98% YoY from $30.8 million in Q4 2020, and down 25.98% on a QoQ basis from $30.8 million in Q4 2020.
Legend Biotech (LEGN) Long-Term Deferred Tax (2019 - 2021) Analysis & Trends
Legend Biotech (LEGN) has 3 years of Long-Term Deferred Tax data on file, last reported at $22.8 million in Q4 2021.
- Quarterly Long-Term Deferred Tax fell 25.98% year-over-year to $22.8 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $22.8 million (down 25.98% YoY) and the FY2021 annual result came in at $22.8 million, down 25.98% from the prior year.
- Long-Term Deferred Tax eased to $22.8 million in Q4 2021, from $30.8 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $30.8 million in Q4 2020 to a low of $5.7 million in Q4 2019.
- A 3-year average of $19.8 million and a median of $22.8 million in 2021 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2020 — Long-Term Deferred Tax jumped 438.86% — and 2021, when it fell 25.98%.
- Tracing LEGN's Long-Term Deferred Tax over 3 years: stood at $5.7 million in 2019, then jumped by 438.86% to $30.8 million in 2020, then slipped by 25.98% to $22.8 million in 2021.
- The last three Long-Term Deferred Tax figures came in at $22.8 million (Q4 2021), $30.8 million (Q4 2020), and $5.7 million (Q4 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 22.80 Mn |
| Dec 31, 2020 | 30.80 Mn |
| Dec 31, 2019 | 5.72 Mn |